Bharat Biotech in talks to take COVID-19 vaccine candidate global

The potential vaccine was found to be safe without any major adverse events in the first two stages of the trials involving about 1,000 people, Executive Director Sai Prasad said in a phone interview, adding that more than 90% of them developed antibodies against the novel coronavirus.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/31zO2Ut
via IFTTT